Endo International Ordinary Shares reported $5.65M in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amarin AMRN:US USD -3883000 60.92M
Coherus Biosciences CHRS:US USD -86650000 36.5M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Hikma Pharmaceutical HIK:LN USD 251M 28M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Novartis NOVN:VX USD 4.06B 72M
Patterson Companies PDCO:US USD 77.84M 37.43M
Pfizer PFE:US USD 10.67B 3.11B
Revance Therapeutics RVNC:US USD -83993000 22.56M
Supernus Pharmaceuticals SUPN:US USD -444000 11.77M
Takeda 4502:JP JPY 64.55B 90.92B
Teva Pharmaceutical TEVA:IT USD 768M 1.93B